Myocardial Tumors in Dogs (Cardiac Muscle Tumors)
- Occurrence: very rare
- Location of disease: Chest
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Das Wichtigste auf einen Blick
Myocardial tumors in dogs are rare but serious diseases that affect the heart muscle. These tumors can arise primarily in the heart or reach it secondarily through metastases from other parts of the body. The exact causes are unclear; however, genetic factors, environmental conditions, and possibly chronic inflammation play a role. Symptoms include cardiac arrhythmias, cough, reduced exercise tolerance, and in severe cases, shortness of breath or cardiovascular collapse. Diagnosis is made through clinical examinations and imaging procedures such as ultrasound and X-ray, supplemented by ECGs and possibly biopsies.
Treatment depends on the tumor type, size, and the dog’s health status. Options include surgery, chemotherapy, and radiation therapy, although tumor removal is often complex. Symptomatic support to improve heart function may also be required. The prognosis varies greatly, with benign tumors offering better prospects than malignant ones. Without treatment, myocardial tumors can quickly lead to Heart failure, and even with treatment, life expectancy is often limited.
Preventive measures are limited, as the exact causes are not known. Regular veterinary check-ups and a healthy lifestyle can help minimize the risk. Research is focusing on genetic and molecular foundations as well as the development of new diagnostic and treatment methods, including noninvasive techniques and immunotherapies.
Ursachen
A dog’s heart consists of four chambers: two atria and two ventricles. The heart muscle, also called the myocardium, is responsible for pumping blood through the body. A disruption in this system, such as that caused by the appearance of a tumor, can impair the efficiency of the heartbeat and lead to a variety of cardiovascular problems.
Myocardial tumors are relatively rare in dogs, but when they occur, they can have significant health impacts. Science distinguishes two main types of tumors in the heart muscle: primary tumors, which originate directly in the heart, and secondary tumors, which spread from other parts of the body. Primary tumors are rarer, while secondary tumors are more common, as they can affect the heart as part of a metastatic process.
The exact causes of myocardial tumors in dogs are not yet fully understood. It is believed that genetic factors play a role, particularly in certain dog breeds that are more susceptible to heart disease. Environmental factors, such as exposure to certain chemicals or radiation, may also increase the risk. In some dogs, pre-existing conditions or a weakened immune system may promote the development of tumors.
A possible cause of myocardial tumors could also be chronic inflammation of the heart tissue. Long-term inflammation can lead to cellular changes that ultimately promote tumor growth. In some dogs, a connection between certain infections and the development of heart tumors is also suspected, although this is rare and requires further research.
Symptoms
The symptoms of myocardial tumors in dogs can be subtle and vary depending on the location and size of the tumor. Some dogs may not show obvious signs until the tumor has reached a considerable size.
Common symptoms include shortness of breath, Cough, Lethargy, and reduced exercise tolerance. These symptoms result from impaired pumping function of the heart, leading to insufficient oxygen supply to the body. Some dogs may also experience fainting spells or weakness, especially after physical exertion.
In advanced cases, fluid accumulation in the abdomen (ascites) or chest (pleural effusion) may occur, leading to visible Swelling and Respiratory distress. Further signs may include heart murmurs, irregular heartbeat, or even sudden collapse and Death.
Diagnose
The diagnosis of myocardial tumors usually begins with a thorough clinical examination and a detailed medical history. The veterinarian will look for signs of heart failure and other symptoms that might indicate a heart problem.
Imaging techniques are crucial for diagnosis. A heart ultrasound (echocardiogram) can help assess the structure and function of the heart and identify tumors in the heart muscle. Chest X-rays can also be used to detect changes in or around the heart, such as fluid accumulation.
Additional tests such as an electrocardiogram (ECG) can detect irregular heart rhythms caused by a tumor. In some cases, a magnetic resonance imaging (MRI) or a computed tomography (CT) may be necessary to obtain a more precise image of the tumor. A biopsy of the tumor tissue can be performed to determine the type of tumor, although this can be risky in heart operations.
Therapie
The treatment of myocardial tumors depends on the type of tumor, its size and location, and the overall health of the dog. Treatment options include surgical procedures, chemotherapy, and radiation therapy.
If the tumor is operable, surgical removal may be considered. However, this option is often complex and risky, as the heart is a sensitive organ and the surgery itself can be life-threatening. In many cases, complete removal of the tumor is not possible.
Chemotherapy can help slow or stop tumor growth, especially in malignant tumors. The selection of medications and the duration of treatment depend on the type of tumor and the dog’s response to therapy.
Radiation therapy can be used in some cases, especially if the tumor cannot be surgically removed. This therapy aims to destroy tumor cells and control tumor growth.
In addition to specific tumor treatment, symptomatic support may be important. Medications to support heart function, such as diuretics and ACE inhibitors, can help relieve symptoms and improve the dog’s quality of life.
Prognose und Nachsorge
The prognosis for dogs with myocardial tumors varies greatly and depends on various factors, including the type of tumor, its size and location, and the stage of the disease at the time of diagnosis.
Benign tumors that can be successfully removed offer a better prognosis than malignant tumors, which are often more aggressive and can form metastases. Unfortunately, malignant tumors in the heart are often difficult to treat, and the long-term prognosis is unfavorable in many cases.
Without treatment, myocardial tumors can quickly lead to Heart failure. Even with treatment, life expectancy is often limited, with the dog’s quality of life being paramount. However, in some dogs, early detection and treatment can prolong life and alleviate symptoms.
Prävention
Since the exact causes of myocardial tumors are not fully understood, there are no specific prevention measures. However, general health care and regular veterinary check-ups can help detect and treat health problems early.
A balanced diet, regular exercise, and avoiding environmental toxins can contribute to the dog’s general health and potentially reduce the risk of tumor development. For dogs with a genetic predisposition to heart disease, regular monitoring by the veterinarian may be useful for early intervention.
It is also important to pay attention to the health of the immune system, as a strong immune system can help reduce the risk of Tumors. Vaccinations and parasite control should be kept up to date to avoid infections that could weaken the immune system.
Ausblick auf aktuelle Forschung
Research into myocardial tumors in dogs has made progress in recent years as the understanding of the pathophysiology of this disease increases. Scientists are focusing on better understanding the genetic and molecular basis of heart muscle tumors to develop earlier diagnosis methods and more effective treatment strategies. One of the main directions is the investigation of genetic anomalies that can promote the growth of tumors in the heart muscle. It is suspected that certain genetic mutations in dogs may increase the risk of developing myocardial tumors. These genetic markers could play a role in early detection in the future.
Another area of research is the development of non-invasive diagnostic tools. Currently, imaging techniques such as ultrasound and MRI are the main methods for diagnosing myocardial tumors. Researchers are working to improve these techniques to detect smaller tumors earlier and characterize them more accurately. Advances in imaging technology could enable a more precise differentiation between benign and malignant tumors, which is crucial for determining appropriate treatment strategies.
Regarding therapy, new approaches to treating heart muscle tumors in dogs are being researched. Traditional treatments include surgical procedures, which are often risky due to the location of the tumors. Therefore, less invasive and more effective treatment methods are being sought. Research focuses on chemotherapy and targeted therapies that specifically target the molecular properties of tumor cells. These therapies could slow or stop tumor growth without damaging surrounding healthy tissue.
Another promising area is immunotherapy, which aims to strengthen the dog’s immune system to fight tumor cells more effectively. However, these therapeutic approaches are still in an early stage of development, and further studies are needed to assess their efficacy and safety. Overall, research on myocardial tumors in dogs shows that an interdisciplinary approach combining veterinary, genetic, and biotechnological insights is promising for improving the diagnosis and treatment of this disease.
Frequently Asked Questions (FAQs)
1. What are myocardial tumors?
2. What symptoms do dogs with myocardial tumors experience?
3. How are myocardial tumors diagnosed in dogs?
4. What treatment options are available for myocardial tumors in dogs?
5. Can myocardial tumors in dogs be cured?
6. Which dog breeds are most commonly affected by myocardial tumors?
7. How can the risk of myocardial tumors in dogs be reduced?
8. Are myocardial tumors common in dogs?
9. How long can a dog live with a myocardial tumor?
10. What progress has been made in research on myocardial tumors in dogs?
Literatur
- Ware, W. A., & Hopper, D. L. (1999). Cardiac tumors in dogs: 1982–1995. Journal of Veterinary Internal Medicine, 13(2), 95–103. https://doi.org/10.1111/j.1939-1676.1999.tb01136.x
- Treggiari, E., Pedro, B., Dukes-McEwan, J., Gelzer, A. R. M., & Blackwood, L. (2017). A descriptive review of cardiac tumours in dogs and cats. Veterinary and Comparative Oncology, 15(2), 273–288. https://doi.org/10.1111/vco.12167
- Aupperle, H., März, I., Ellenberger, C., Buschatz, S., Reischauer, A., & Schoon, H.-A. (2007). Primary and secondary heart tumours in dogs and cats. Journal of Comparative Pathology, 136(1), 18–26. https://doi.org/10.1016/j.jcpa.2006.10.002
- Rajagopalan, V., Jesty, S. A., Craig, L. E., & Gompf, R. E. (2013). Comparison of presumptive echocardiographic and definitive diagnoses of cardiac tumors in dogs. Journal of Veterinary Internal Medicine, 27(5), 1092–1096. https://doi.org/10.1111/jvim.12134
- MacDonald, K. A., Cagney, O., & Magne, M. L. (2009). Echocardiographic and clinicopathologic characterization of pericardial effusion in dogs: 107 cases (1985–2006). Journal of the American Veterinary Medical Association, 235(12), 1456–1461. https://doi.org/10.2460/javma.235.12.1456
- Lew, F. H., McQuown, B., Borrego, J., Cunningham, S., & Burgess, K. E. (2019). Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011–2018. Veterinary and Comparative Oncology, 17(4), 465–471. https://doi.org/10.1111/vco.12491
- Aronsohn, M. (1985). Cardiac hemangiosarcoma in the dog: A review of 38 cases. Journal of the American Veterinary Medical Association, 187(9), 922–926.
- Wakamatsu, C. N., Kelsey, K. L., Ruslander, D. M., & Nolan, M. W. (2025). Retrospective study evaluating outcomes following palliative radiotherapy with or without chemotherapy for dogs with presumed cardiac hemangiosarcoma. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13068